(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 4.21% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.29%.
Azenta's revenue in 2026 is $596,330,000.On average, 9 Wall Street analysts forecast AZTA's revenue for 2026 to be $28,230,459,666, with the lowest AZTA revenue forecast at $26,420,395,253, and the highest AZTA revenue forecast at $29,261,094,763. On average, 9 Wall Street analysts forecast AZTA's revenue for 2027 to be $29,596,650,376, with the lowest AZTA revenue forecast at $27,165,715,893, and the highest AZTA revenue forecast at $30,925,966,844.
In 2028, AZTA is forecast to generate $31,736,278,338 in revenue, with the lowest revenue forecast at $29,586,970,888 and the highest revenue forecast at $33,370,268,240.